Pseudomonas exotoxin has been genetically modified so that it targets cancer cells. This was accomplished by deleting its cell binding domain and replacing it with Fv fragments of antibodies that react with breast, colon, and other cancers. Several recombinant immunotoxins are now in clinical trials.
Key wordsbreast cancer cancer treatment colon cancer Pseudomonas exotoxin
Unable to display preview. Download preview PDF.
- 13.Baeckstrom D, Hansson GC, Nilsson O, Johansson C, Gendler SJ, Lindholm L: Purification and characterization of a membrane-bound and a secreted mucintype glycoprotein carrying the carcinoma-associated sialyl-LEA epitope on distinct core proteins. J Biol Chem 266:21537–21547, 1991.PubMedGoogle Scholar